Search
Recently, the National Healthcare Security Administration convened a symposium focused on bolstering innovative drugs and medical devices through healthcare insurance. The symposium introduced several novel initiatives aimed at expediting the clinical integration of novel pharmaceutical technologies and products. Among these measures are the exploration and implementation of a first-sale pricing mechanism for newly marketed drugs, the refinement of online listing services by category to stimulate innovation in drug research and development, and efforts to facilitate the global reach of China's innovative drugs and medical devices. These strategies are designed to cater to the diverse medical and medication needs of the public while fostering high-quality development in the realm of innovative pharmaceuticals.
-
C114 Communication Network -
Communication Home
